CN114980869B - 外排体模拟物的大规模产生及其用途 - Google Patents

外排体模拟物的大规模产生及其用途 Download PDF

Info

Publication number
CN114980869B
CN114980869B CN202080072463.2A CN202080072463A CN114980869B CN 114980869 B CN114980869 B CN 114980869B CN 202080072463 A CN202080072463 A CN 202080072463A CN 114980869 B CN114980869 B CN 114980869B
Authority
CN
China
Prior art keywords
exosome
disease
mimetic
cancer
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202080072463.2A
Other languages
English (en)
Chinese (zh)
Other versions
CN114980869A (zh
Inventor
玛莎·A·莫塞斯
郭鹏
戈尔纳兹·穆拉德
黄静
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Children's Hospital
Original Assignee
Boston Children's Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Children's Hospital filed Critical Boston Children's Hospital
Publication of CN114980869A publication Critical patent/CN114980869A/zh
Application granted granted Critical
Publication of CN114980869B publication Critical patent/CN114980869B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1896—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes not provided for elsewhere, e.g. cells, viruses, ghosts, red blood cells, virus capsides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4058—Detecting, measuring or recording for evaluating the nervous system for evaluating the central nervous system
    • A61B5/4064—Evaluating the brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0033—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room
    • A61B5/0035—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for acquisition of images from more than one imaging mode, e.g. combining MRI and optical tomography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0033—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room
    • A61B5/004—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part
    • A61B5/0042—Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part for the brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Botany (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Psychology (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
CN202080072463.2A 2019-08-16 2020-08-13 外排体模拟物的大规模产生及其用途 Active CN114980869B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962887876P 2019-08-16 2019-08-16
US62/887,876 2019-08-16
PCT/US2020/046050 WO2021034582A1 (en) 2019-08-16 2020-08-13 Large scale production of exosome mimetics and uses thereof

Publications (2)

Publication Number Publication Date
CN114980869A CN114980869A (zh) 2022-08-30
CN114980869B true CN114980869B (zh) 2024-08-27

Family

ID=74659601

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080072463.2A Active CN114980869B (zh) 2019-08-16 2020-08-13 外排体模拟物的大规模产生及其用途

Country Status (6)

Country Link
US (1) US20220288241A1 (cg-RX-API-DMAC7.html)
EP (1) EP4013391A4 (cg-RX-API-DMAC7.html)
JP (1) JP7765681B2 (cg-RX-API-DMAC7.html)
CN (1) CN114980869B (cg-RX-API-DMAC7.html)
CA (1) CA3150734A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021034582A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12241888B2 (en) 2018-03-14 2025-03-04 Children's Medical Center Corporation Platform for assessment of the transcytosis of extracellular vesicles across endothelial barriers and uses thereof
CN115137723B (zh) * 2022-09-06 2023-05-05 深圳市茵冠生物科技有限公司 醋酸钙梯度主动载药法制备维a酸外泌体模拟物
CN116200392B (zh) * 2023-02-24 2026-08-11 杭州佰辰医学检验所有限公司 特异性结合丙戊酸钠小分子的核酸适配体、试剂盒及应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019151744A1 (ko) * 2018-01-31 2019-08-08 서울대학교산학협력단 성체줄기세포 유래의 나노베시클 및 이의 표적 치료용 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5667180B2 (ja) * 2009-07-01 2015-02-12 イオン メディックス インコーポレイテッド 哺乳類の有核細胞に由来するマイクロベシクル及びその用途
EA037503B1 (ru) * 2014-01-21 2021-04-05 Анджариум Байосайенсиз Аг Способ получения гибридосомы, гибридосома, полученная при помощи способа, и способ доставки терапевтического или диагностического средства
KR101720851B1 (ko) * 2015-01-29 2017-03-28 포항공과대학교 산학협력단 세포의 지질막에서 유래된 나노소포체 및 이의 용도
CN108175759B (zh) * 2016-12-08 2021-03-19 暨南大学 一种抗肿瘤靶向给药系统及其制备方法与应用

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019151744A1 (ko) * 2018-01-31 2019-08-08 서울대학교산학협력단 성체줄기세포 유래의 나노베시클 및 이의 표적 치료용 용도

Also Published As

Publication number Publication date
EP4013391A4 (en) 2023-08-09
CN114980869A (zh) 2022-08-30
EP4013391A1 (en) 2022-06-22
JP2022545656A (ja) 2022-10-28
US20220288241A1 (en) 2022-09-15
CA3150734A1 (en) 2021-02-25
JP7765681B2 (ja) 2025-11-07
WO2021034582A1 (en) 2021-02-25

Similar Documents

Publication Publication Date Title
Srivastava et al. Exploitation of exosomes as nanocarriers for gene-, chemo-, and immune-therapy of cancer
Yan et al. Engineering cell membrane‐based nanotherapeutics to target inflammation
Pulford et al. Liposome-siRNA-peptide complexes cross the blood-brain barrier and significantly decrease PrPC on neuronal cells and PrPRES in infected cell cultures
US20180311377A1 (en) Drug delivery systems using fc fragments
US12018080B2 (en) Methods and compositions for treating cancer by targeting the CLEC2D-KLRB1 pathway
CN107427466B (zh) 从细胞膜衍生的纳米囊泡及其用途
CA2787156C (en) Synthetic nanostructures for delivery of oligonucleotides
RU2570636C2 (ru) Микровезикулы, происходящие из протопластов клеток, и их применение
JP7765681B2 (ja) エクソソーム模倣物のラージスケール生成およびそれらの使用
US20150010475A1 (en) Crlf-2 binding peptides, protocells and viral-like particles useful in the treatment of cancer, including acute lymphoblastic leukemia (all)
KR20160110410A (ko) 하이브리도좀, 이를 포함하는 조성물, 이의 제조 방법 및 이의 용도
CN102596177A (zh) 来源于有核哺乳动物细胞的微囊泡及其应用
WO2011158933A1 (ja) 腎線維症処置剤
US20240058454A1 (en) Biological delivery systems
JP2024133452A (ja) セラミド様脂質ベースの送達ビヒクルおよびその使用
EP4532024A1 (en) Allogeneic hypoimmune biomimetic nanovesicle for the treatment of cancer
CN119403924A (zh) 用于产生仿生纳米囊泡的低免疫原性细胞
CN119486765A (zh) 仿生纳米囊泡和外泌体中管腔局部有效负载的治疗相关生物分子的受控表达
JP2021501161A (ja) 短鎖セラミドベースの脂質およびその使用
US20220275371A1 (en) Use of rab7 gtpase (rab7) inhibitors in enhancing permeability of the blood brain barrier (bbb)
US12551451B2 (en) Compositions and methods for delivering molecules
US20230357353A1 (en) MAdCAM-1 POLYPEPTIDES AND USES THEREOF
Jain et al. A novel method for producing functionalized vesicles that efficiently deliver oligonucleotides in vitro and in vivo in mice
Sork Profiling and exploiting lipid-based nanoparticles in vitro and in vivo
Nassar et al. Extracellular vesicles: fundamentals and clinical relevance

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant